(Q37066971)

18 August 2017

Persistent intrathecal immune activation in HIV-1-infected individuals on antiretroviral therapy (English)

1 reference

18 August 2017

0 references

anti-retroviral agent

0 references

4

Dietmar Fuchs

1 reference

18 August 2017

2

Richard W Price

1 reference

18 August 2017

5

Lars Hagberg

1 reference

18 August 2017

3

Serena Spudich

1 reference

18 August 2017

1

Aylin Yilmaz

1 reference

18 August 2017

Magnus Gisslén

6

1 reference

PMCID

2628632

18 August 2017

language of work or name

English

0 references

publication date

1 February 2008

1 reference

Journal of Acquired Immune Deficiency Syndromes

18 August 2017

1 reference

18 August 2017

47

1 reference

18 August 2017

2

1 reference

18 August 2017

168-173

1 reference

Compartmentalized human immunodeficiency virus type 1 present in cerebrospinal fluid is produced by short-lived cells

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: a combined study of two cohorts.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Neopterin in HIV-1 infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Changing incidence of central nervous system diseases in the EuroSIDA cohort

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Continuing intrathecal immunoactivation despite two years of effective antiretroviral therapy against HIV-1 infection

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Prevalence and predictive value of intermittent viremia with combination hiv therapy

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Cerebrospinal fluid HIV RNA originates from both local CNS and systemic sources

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Cerebrospinal fluid neopterin concentrations in central nervous system infection

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Antiretroviral treatment of HIV infection: Swedish recommendations 2005.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Efficacy of cerebrospinal fluid (CSF)-penetrating antiretroviral drugs against HIV in the neurological compartment: different patterns of phenotypic resistance in CSF and plasma

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Cerebrospinal fluid and plasma HIV-1 RNA levels and lopinavir concentrations following lopinavir/ritonavir regimen

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Differences in the detection of three HIV-1 protease inhibitors in non-blood compartments: clinical correlations

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

A single-dose study to assess the penetration of stavudine into human cerebrospinal fluid in adults.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2628632

Cerebrospinal fluid and plasma viral load in HIV-1-infected patients with various anti-retroviral treatment regimens

4 September 2018

1 reference

12 December 2020

Cerebrospinal fluid viral loads reach less than 2 copies/ml in HIV-1-infected patients with effective antiretroviral therapy

1 reference

12 December 2020

Determination of neopterin in serum and urine

1 reference

12 December 2020

CSF neopterin as marker of disease activity in multiple sclerosis

1 reference

12 December 2020

Significance of CSF total neopterin and biopterin in inflammatory neurological diseases

1 reference

12 December 2020

Penetration of zidovudine into the cerebrospinal fluid of patients infected with HIV

1 reference

12 December 2020

Commercial enzyme-linked immunosorbent assay for neopterin detection in blood donations compared with RIA and HPLC

1 reference

12 December 2020

Intrathecal immunoactivation in patients with HIV-1 infection is reduced by zidovudine but not by didanosine

1 reference

12 December 2020

Cerebrospinal fluid viral load, intrathecal immunoactivation, and cerebrospinal fluid monocytic cell count in HIV-1 infection

1 reference

12 December 2020

Cerebrospinal fluid HIV-1 infection usually responds well to antiretroviral treatment

1 reference

12 December 2020

10.1097/QAI.0B013E31815ACE97

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

1 reference

PMCID

2628632